351 related articles for article (PubMed ID: 28600290)
1. High-Throughput Single-Cell Analysis of B Cell Receptor Usage among Autoantigen-Specific Plasma Cells in Celiac Disease.
Roy B; Neumann RS; Snir O; Iversen R; Sandve GK; Lundin KEA; Sollid LM
J Immunol; 2017 Jul; 199(2):782-791. PubMed ID: 28600290
[TBL] [Abstract][Full Text] [Related]
2. Analysis of celiac disease autoreactive gut plasma cells and their corresponding memory compartment in peripheral blood using high-throughput sequencing.
Snir O; Mesin L; Gidoni M; Lundin KE; Yaari G; Sollid LM
J Immunol; 2015 Jun; 194(12):5703-12. PubMed ID: 25972486
[TBL] [Abstract][Full Text] [Related]
3. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
[TBL] [Abstract][Full Text] [Related]
4. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
[TBL] [Abstract][Full Text] [Related]
5. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM
Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952
[TBL] [Abstract][Full Text] [Related]
6. B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.
du Pré MF; Blazevski J; Dewan AE; Stamnaes J; Kanduri C; Sandve GK; Johannesen MK; Lindstad CB; Hnida K; Fugger L; Melino G; Qiao SW; Sollid LM
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31727780
[TBL] [Abstract][Full Text] [Related]
7. Responsive population dynamics and wide seeding into the duodenal lamina propria of transglutaminase-2-specific plasma cells in celiac disease.
Di Niro R; Snir O; Kaukinen K; Yaari G; Lundin KE; Gupta NT; Kleinstein SH; Cols M; Cerutti A; Mäki M; Shlomchik MJ; Sollid LM
Mucosal Immunol; 2016 Jan; 9(1):254-64. PubMed ID: 26153762
[TBL] [Abstract][Full Text] [Related]
8. Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells.
Steinsbø Ø; Henry Dunand CJ; Huang M; Mesin L; Salgado-Ferrer M; Lundin KE; Jahnsen J; Wilson PC; Sollid LM
Nat Commun; 2014 Jun; 5():4041. PubMed ID: 24909383
[TBL] [Abstract][Full Text] [Related]
9. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
11. Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
Hnida K; Stamnaes J; du Pré MF; Mysling S; Jørgensen TJ; Sollid LM; Iversen R
J Biol Chem; 2016 Dec; 291(49):25542-25552. PubMed ID: 27784785
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease.
Chen X; Hnida K; Graewert MA; Andersen JT; Iversen R; Tuukkanen A; Svergun D; Sollid LM
J Biol Chem; 2015 Aug; 290(35):21365-75. PubMed ID: 26160175
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies and CD: past and future of celiac antibody testing.
Korponay-Szabó IR
J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S11-3. PubMed ID: 24979192
[TBL] [Abstract][Full Text] [Related]
14. Generation of circulating autoreactive pre-plasma cells fueled by naive B cells in celiac disease.
Lindeman I; Høydahl LS; Christophersen A; Risnes LF; Jahnsen J; Lundin KEA; Sollid LM; Iversen R
Cell Rep; 2024 Apr; 43(4):114045. PubMed ID: 38578826
[TBL] [Abstract][Full Text] [Related]
15. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
[TBL] [Abstract][Full Text] [Related]
16. Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus.
Kasaian MT; Ikematsu H; Balow JE; Casali P
J Immunol; 1994 Mar; 152(6):3137-51. PubMed ID: 8144908
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of naïve B cells with unique epitope specificity shapes autoantibody formation in celiac disease.
Das S; Stamnaes J; Høydahl LS; Skagen C; Lundin KEA; Jahnsen J; Sollid LM; Iversen R
J Autoimmun; 2024 Jun; 146():103241. PubMed ID: 38754235
[TBL] [Abstract][Full Text] [Related]
18. T-cell and B-cell immunity in celiac disease.
du Pré MF; Sollid LM
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):413-23. PubMed ID: 26060106
[TBL] [Abstract][Full Text] [Related]
19. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341
[TBL] [Abstract][Full Text] [Related]
20. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease.
Marzari R; Sblattero D; Florian F; Tongiorgi E; Not T; Tommasini A; Ventura A; Bradbury A
J Immunol; 2001 Mar; 166(6):4170-6. PubMed ID: 11238668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
